Chemed earnings were $282.4M for the trailing 12 months ending Sep 30, 2026, with 10% growth year over year. The latest CHE earnings report on Sep 30, 2026 announced Q3 2026 earnings of $71.6M, up 5.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CHE reported annual earnings of $265.2M, with -12.2% growth.
CHE past earnings growth
How has CHE's earnings growth performed historically?
On CHE's earnings call on Oct 27, 2026, Chemed (NYSE: CHE) reported Q3 2026 earnings per share (EPS) of $5.49, up 23.09% year over year. Total CHE earnings for the quarter were $71.65 million. In the same quarter last year, Chemed's earnings per share (EPS) was $4.46.
As of the last Chemed earnings report, Chemed is currently profitable. Chemed's net profit (also called net income) for the twelve months ending Sep 30, 2026 was $282.40 million, a 1.29% increase year over year.
What was CHE's earnings growth in the past year?
As of Chemed's earnings date in Oct 27, 2026, Chemed's earnings has grown 9.98% year over year. This is 37.39 percentage points lower than the US Medical Care Facilities industry earnings growth rate of 47.38%. CHE earnings in the past year totalled $282.40 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.